期刊文献+

抗中性粒细胞胞浆抗体相关性血管炎的治疗 被引量:1

下载PDF
导出
作者 杨光 胡伟新
出处 《肾脏病与透析肾移植杂志》 CAS CSCD 2005年第6期550-554,共5页 Chinese Journal of Nephrology,Dialysis & Transplantation
  • 相关文献

参考文献34

  • 1Levy JB.New aspects in the management of ANCA positive vasculitis.Nephrol Dial Transplant,2001,16:1314-1317.
  • 2Jayne DR,Rasmussen N.Treatment of antineutrophil cytoplasm autoantibody-associated systemic vasculitis:initiatives of the European Community Systemic Vasculitis Clinical Trials Study Group.Mayo Clin Proc,1997,72(8):737-747.
  • 3Klemmer PJ,Chalermskulrat W,Reif MS,et al.Plasmapheresis therapy for diffuse alveolar hemorrhage in patients with small-vessel vasculitis.Am J Kidney Dis,2003,42:1149-1153.
  • 4de Groot K,Adu D,Savage CO.The value of pulse cyclophosphamide in ANCA associated vasculitis:Meta analysis and critical review.Nephrol Dial Transplant,2001,16:2018-2027.
  • 5刘志红,黎磊石.霉酚酸酯在重症狼疮性肾炎中的应用[J].肾脏病与透析肾移植杂志,2002,11(6):537-538. 被引量:19
  • 6胡伟新,唐政,程震,章海涛,陈惠萍,刘志红,黎磊石.霉酚酸酯治疗Ⅲ型新月体肾炎(附3例报道)[J].肾脏病与透析肾移植杂志,1999,8(4):323-326. 被引量:17
  • 7胡伟新,陈欣,姚小丹,唐政,陈惠萍,刘志红,黎磊石.霉酚酸酯治疗小血管炎肾损害的临床研究[J].肾脏病与透析肾移植杂志,2002,11(2):110-115. 被引量:29
  • 8胡伟新,刘春蓓,谢红浪,王庆文,陈惠萍,刘志红,黎磊石.霉酚酸酯与环磷酰胺治疗ANCA相关血管炎的临床对照研究[J].肾脏病与透析肾移植杂志,2005,14(6):501-507. 被引量:27
  • 9Joy MS,Hogan SL,Jennette JC,et al.A pilot study using mycophenolate mofetil in relapsing or resistant ANCA small vessel vasculitis.Nephrol Dial Transplant,2005,20 (12):2725-2732.
  • 10Specks U,Fervenza FC,McDonald TJ,et al.Response of Wegener's granulomatosis to anti-CD20 chimeric monoclonal antibody therapy.Arthritis Rheum,2001,44:2836-2840.

二级参考文献36

  • 1胡伟新,刘春蓓,唐政,俞雨生,王庆文,陈惠萍,刘志红,黎磊石.微型多血管炎肾损害的预后[J].肾脏病与透析肾移植杂志,2004,13(5):419-425. 被引量:11
  • 2胡伟新 唐政 等.霉酚酸酯治疗IV型狼疮性肾炎的临床和病理研究(待发表)[J].-,.
  • 3Levy JB.New aspects in the management of ANCA positive vasculitis.Nephrol Dial Transplant,2001,16:1314-1317.
  • 4Jayne D,Rasmussen N,Andrassy K,et al.Randomized trial of CTXlophosphamide versus azathioprine as remission maintenance therapy for ANCA-associated vasculitis.N Engl J Med,2003,349:36-44.
  • 5Little MA,Nazar L,Farrington K.Outcome in glomerulonephritis due to systemic small vessel vasculitis:Effect of functional status and non-vasculitic co-morbidity.Nephrol Dial Transplant,2004,19:356-364.
  • 6Hu WX,Liu ZH,Chen HP,et al.Mycophenolate mofetil vs cyclophosphamide therapy for patients with diffuse proliferative lupus nephritis.Chin Med J,2002,115 (5):705-709.
  • 7Jennette JC,Falk R J,Andrassy K.Nomenclature of systemic vasculitides.Proposal of an international consensus conference.Arthritis Rheum,1994,37:187-192.
  • 8Luqmani RA,Bacon PA,Moots RJ,et al.Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis.Q J Med,1994,87:671-678.
  • 9Exley AR,Bacon PA,Luqmani RA,et al.Development and initial validation of the Vasculitis Damage Index for the standardized clinical assessment of damage in the systemic vasculitides.Arthritis Rheum,1997,40:371-380.
  • 10Joy MS,Hogan SL,Jennette JC,et al.A pilot study using mycophenolate mofetil in relapsing or resistant ANCA small vessel vasculitis.Nephrol Dial Transplant,2005,20 (12):2725-2732.

共引文献83

同被引文献2

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部